Arkin Holdings raises $270 million for new biotech fund
The new fund, which will be named Arkin Bio-Capital, intends to invest in 8-10 companies that are developing innovative medicine and plan on going public in the near future
Meir Orbach | 10:45 27.10.2021
Arkin Holdings, whose funds have $2 billion in assets under management, has raised $270 million for a new fund it has named Arkin Bio-Capital. In addition to Arkin Holdings, the fund received investments from Migdal Insurance, Phoenix, who invested in prior funds as well, in addition to new institutional investors: Harel Insurance, Menorah Insurance, More Investment House, and Leumi Partners. The fund is expected to invest in companies across the world. The new fund, which will be managed by Alon Lazarus and Pini Orbach, intends to invest in 8-10 companies that are developing innovative medicine for diseases that require a clear medical intervention and plan on going public in the near future.